Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries

The Central European Cooperative Oncology Group (CECOG) and ‘ESMO Open—Cancer Horizons’ roundtable discussion brought together stakeholders from several European Union (EU) countries involved in drug development, drug authorisation and reimbursement or otherwise affected by delayed and unequal acces...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilking, Nils, Bucsics, Anna, Kandolf Sekulovic, Lidlija, Kobelt, Gisela, Laslop, Andrea, Makaroff, Lydia, Roediger, Alexander, Zielinski, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863652/
https://www.ncbi.nlm.nih.gov/pubmed/31798977
http://dx.doi.org/10.1136/esmoopen-2019-000550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863652/
https://www.ncbi.nlm.nih.gov/pubmed/31798977
http://dx.doi.org/10.1136/esmoopen-2019-000550

Ejemplares similares